134 related articles for article (PubMed ID: 38038384)
1. Unveiling the anticancer mechanism of 1,2,3-triazole-incorporated thiazole-pyrimidine-isoxazoles: insights from docking and molecular dynamics simulations.
Sireesha R; Pavani Y; Mallavarapu BD; Abbasi BA; Guttula PK; Subbarao M
J Biomol Struct Dyn; 2023 Dec; ():1-13. PubMed ID: 38038384
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological profile and computational insights of new derivatives of benzo [B][1,4] diazepines as prospective anticancer agents for inhibiting the CDK-2 protein.
Dar PA; Bhat BA; Mir MA; Chaudhari SY; Shah WA
J Biomol Struct Dyn; 2024 Feb; ():1-16. PubMed ID: 38344942
[TBL] [Abstract][Full Text] [Related]
4. Computational and Molecular Docking Studies of New Benzene Sulfonamide Drugs with Anticancer and Antioxidant Effects.
Mohamed HS; Abdelgawad MA; Hegab M; Hamza ZS; Nagdy AM; Ahmed SA; Ahmed OM; Ghoneim MM
Curr Org Synth; 2023; 20(3):339-350. PubMed ID: 36214306
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, anticancer evaluation and molecular docking studies of 1,2,3-triazole incorporated 1,3,4-oxadiazole-Triazine derivatives.
Oggu S; Akshinthala P; Katari NK; Nagarapu LK; Malempati S; Gundla R; Jonnalagadda SB
Heliyon; 2023 May; 9(5):e15935. PubMed ID: 37206039
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
7. Thiazole-Based Thiosemicarbazones: Synthesis, Cytotoxicity Evaluation and Molecular Docking Study.
Gomha SM; Abdelhady HA; Hassain DZH; Abdelmonsef AH; El-Naggar M; Elaasser MM; Mahmoud HK
Drug Des Devel Ther; 2021; 15():659-677. PubMed ID: 33633443
[TBL] [Abstract][Full Text] [Related]
8.
Kumar S; Ali I; Abbas F; Rana A; Pandey S; Garg M; Kumar D
J Biomol Struct Dyn; 2023 Aug; ():1-23. PubMed ID: 37646177
[TBL] [Abstract][Full Text] [Related]
9. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
10. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
[TBL] [Abstract][Full Text] [Related]
11. Molecular docking studies, biological evaluation and synthesis of novel 3-mercapto-1,2,4-triazole derivatives.
Ghanaat J; Khalilzadeh MA; Zareyee D
Mol Divers; 2021 Feb; 25(1):223-232. PubMed ID: 32067134
[TBL] [Abstract][Full Text] [Related]
12. Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies.
Parmar DR; Soni JY; Guduru R; Rayani RH; Kusurkar RV; Vala AG; Talukdar SN; Eissa IH; Metwaly AM; Khalil A; Zunjar V; Battula S
Bioorg Chem; 2021 Oct; 115():105206. PubMed ID: 34339975
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, Anticancer Evaluation, and Molecular Docking Studies of Oxazole-Incorporated Naphthyridine Derivatives.
Rangaswamy S; Sreenivasulu R; Babu VR; Syed T; Kapavarapu RK; Jayaprakash HV; Abbaraju VDNK
Chem Biodivers; 2023 Dec; 20(12):e202300466. PubMed ID: 37864549
[TBL] [Abstract][Full Text] [Related]
14. Anticancer Activity and In Silico ADMET Properties of 2,4,5-Trisubstitutedthiazole Derivatives.
Al-Jaidi BA; Telfah ST; Bardaweel SK; Deb PK; Borah P; Venugopala KN; Bataineh YA; Al Khames Aga QA
Curr Drug Metab; 2021; 22(7):532-536. PubMed ID: 33334285
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a new Bcl-2 inhibitor through synthesis, anticancer activity, docking and MD simulations.
Byadi S; Abdoullah B; Fawzi M; Irrou E; Ait Elmachkouri Y; Oubella A; Auhmani A; Morjani H; Labd Taha M; Robert A; Aboulmouhajir A; Ait Itto MY
J Biomol Struct Dyn; 2024 May; 42(8):4145-4154. PubMed ID: 37255018
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of 1,2,4-Thiadiazole-1,2,4-Triazole Derivatives Bearing Amide Functionality as Anticancer Agents.
Pragathi YJ; Sreenivasulu R; Veronica D; Raju RR
Arab J Sci Eng; 2021; 46(1):225-232. PubMed ID: 32837812
[TBL] [Abstract][Full Text] [Related]
17. Rational design, molecular docking and synthesis of novel homopiperazine linked imidazo[1,2-a]pyrimidine derivatives as potent cytotoxic and antimicrobial agents.
Mantipally M; Gangireddy MR; Gundla R; Badavath VN; Mandha SR; Maddipati VC
Bioorg Med Chem Lett; 2019 Aug; 29(16):2248-2253. PubMed ID: 31239178
[TBL] [Abstract][Full Text] [Related]
18. Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies.
Turky A; Bayoumi AH; Sherbiny FF; El-Adl K; Abulkhair HS
Mol Divers; 2021 Feb; 25(1):403-420. PubMed ID: 32830299
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Biological Evaluation of Novel Heterocyclic Imines Linked Coumarin- Thiazole Hybrids as Anticancer Agents.
Goud NS; Ghouse MS; Vishnu J; Pranay J; Alvala R; Talla V; Qureshi IA; Alvala M
Anticancer Agents Med Chem; 2019; 19(4):557-566. PubMed ID: 30734685
[TBL] [Abstract][Full Text] [Related]
20. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.
Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
